173 related articles for article (PubMed ID: 34910958)
1. Imipramine induces hyperactivity in rats pretreated with ouabain: Implications to the mania switch induced by antidepressants.
Valvassori SS; Cararo JH; Marino CAP; Possamai-Della T; Ferreira CL; Aguiar-Geraldo JM; Dal-Pont GC; Quevedo J
J Affect Disord; 2022 Feb; 299():425-434. PubMed ID: 34910958
[TBL] [Abstract][Full Text] [Related]
2. Depressive-like behavior accompanies neuroinflammation in an animal model of bipolar disorder symptoms induced by ouabain.
Valvassori SS; Aguiar-Geraldo JM; Possamai-Della T; da-Rosa DD; Peper-Nascimento J; Cararo JH; Quevedo J
Pharmacol Biochem Behav; 2022 Sep; 219():173434. PubMed ID: 35901967
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen has an anti-manic effect but not protect the brain against oxidative stress in an animal model of mania induced by ouabain.
Dal-Pont GC; Resende WR; Bianchini G; Gava FF; Peterle BR; Trajano KS; Varela RB; Quevedo J; Valvassori SS
J Psychiatr Res; 2019 Jun; 113():181-189. PubMed ID: 30981159
[TBL] [Abstract][Full Text] [Related]
4. Imipramine Can Be Effective on Depressive-Like Behaviors, but Not on Neurotrophic Factor Levels in an Animal Model for Bipolar Disorder Induced by Ouabain.
Possamai-Della T; Dal-Pont GC; Resende WR; Aguiar-Geraldo JM; Peper-Nascimento J; Quevedo J; Valvassori SS
Mol Neurobiol; 2022 Dec; 59(12):7170-7181. PubMed ID: 36121567
[TBL] [Abstract][Full Text] [Related]
5. Folic acid does not have an anti-manic effect but protect the brain against oxidative stress in an animal model of mania induced by ouabain.
Aguiar-Geraldo JM; Possamai-Della T; Menegas S; Peper-Nascimento J; Quevedo J; Valvassori SS
J Affect Disord; 2023 Aug; 334():307-316. PubMed ID: 37150224
[TBL] [Abstract][Full Text] [Related]
6. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
Jornada LK; Moretti M; Valvassori SS; Ferreira CL; Padilha PT; Arent CO; Fries GR; Kapczinski F; Quevedo J
J Psychiatr Res; 2010 Jun; 44(8):506-10. PubMed ID: 19954800
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of GSK-3β on Behavioral Changes and Oxidative Stress in an Animal Model of Mania.
Dal-Pont GC; Resende WR; Varela RB; Menegas S; Trajano KS; Peterle BR; Quevedo J; Valvassori SS
Mol Neurobiol; 2019 Apr; 56(4):2379-2393. PubMed ID: 30027342
[TBL] [Abstract][Full Text] [Related]
8. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania.
Valvassori SS; Arent CO; Steckert AV; Varela RB; Jornada LK; Tonin PT; Budni J; Mariot E; Kapczinski F; Quevedo J
Mol Neurobiol; 2015 Aug; 52(1):353-62. PubMed ID: 25164569
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain.
Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
Behav Brain Res; 2014 Sep; 271():316-24. PubMed ID: 24959861
[TBL] [Abstract][Full Text] [Related]
11. Validation of the animal model of bipolar disorder induced by Ouabain: face, construct and predictive perspectives.
Valvassori SS; Dal-Pont GC; Resende WR; Varela RB; Lopes-Borges J; Cararo JH; Quevedo J
Transl Psychiatry; 2019 Jun; 9(1):158. PubMed ID: 31164628
[TBL] [Abstract][Full Text] [Related]
12. Ouabain induces memory impairment and alter the BDNF signaling pathway in an animal model of bipolar disorder: Cognitive and neurochemical alterations in BD model.
Valvassori SS; Dal-Pont GC; Varela RB; Resende WR; Gava FF; Mina FG; Budni J; Quevedo J
J Affect Disord; 2021 Mar; 282():1195-1202. PubMed ID: 33601696
[TBL] [Abstract][Full Text] [Related]
13. Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.
Valvassori SS; Dal-Pont GC; Resende WR; Varela RB; Peterle BR; Gava FF; Mina FG; Cararo JH; Carvalho AF; Quevedo J
Int J Neuropsychopharmacol; 2017 Nov; 20(11):877-885. PubMed ID: 29020306
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Se-phenyl-thiazolidine-4-carboselenoate protective activity against oxidative and behavioral stress in the maniac model induced by ouabain in male rats.
Sousa FSS; Seus N; Alves D; Salles HD; Schneider PH; Savegnago L; Castro M
Neurosci Lett; 2017 Jun; 651():182-187. PubMed ID: 28432028
[TBL] [Abstract][Full Text] [Related]
15. Effects of ouabain on cytokine/chemokine levels in an animal model of mania.
Tonin PT; Valvassori SS; Lopes-Borges J; Mariot E; Varela RB; Teixeira AL; Quevedo J
J Neuroimmunol; 2014 Nov; 276(1-2):236-9. PubMed ID: 25288301
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C isoforms as a target for manic-like behaviors and oxidative stress in a dopaminergic animal model of mania.
S Valvassori S; H Cararo J; Peper-Nascimento J; L Ferreira C; F Gava F; C Dal-Pont G; L Andersen M; Quevedo J
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109940. PubMed ID: 32243997
[TBL] [Abstract][Full Text] [Related]
17. Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: Mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway.
Valvassori SS; Resende WR; Lopes-Borges J; Mariot E; Dal-Pont GC; Vitto MF; Luz G; de Souza CT; Quevedo J
J Psychiatr Res; 2015 Jun; 65():63-70. PubMed ID: 25959616
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
Varela RB; Valvassori SS; Lopes-Borges J; Mariot E; Dal-Pont GC; Amboni RT; Bianchini G; Quevedo J
J Psychiatr Res; 2015 Feb; 61():114-21. PubMed ID: 25467060
[TBL] [Abstract][Full Text] [Related]
19. Ouabain, a Na-K-ATPase inhibitor, enhances wakefulness in rats.
Lelkes Z
Neuropharmacology; 2020 Oct; 176():108224. PubMed ID: 32707223
[TBL] [Abstract][Full Text] [Related]
20. Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain.
Valvassori SS; Dal-Pont GC; Steckert AV; Varela RB; Lopes-Borges J; Mariot E; Resende WR; Arent CO; Carvalho AF; Quevedo J
Psychiatry Res; 2016 Jan; 235():154-9. PubMed ID: 26654753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
